EQUITIES
Robust. Fundamental. Dynamic.
Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

$217.4bn
Equities Assets Under Management

153
Equities Investment
Professionals

20
Average Years’
Experience
As at March 31, 2025
![]() $217.4bn |
![]() 153 |
![]() 20 |
As at March 31, 2025
We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.
Featured strategies
Equities Strategies
Global/International
- Global Alpha Equity
- Global Research Equity
- Global Research Growth Equity
- Global Small Cap
- International Alpha Equity
- International Research Equity
US
- US Concentrated Growth
- US Mid Cap Growth
- US Mid Cap Value
- US Opportunistic Alpha
- US Research Core Equity
- US Research Growth Equity
- US Small Cap Growth
- US Small Cap Value
- US SMID Cap Growth
- US SMID Cap Value
Specialty
- Biotechnology Innovation
- Global Life Sciences
- Global Property Equities
- Global Sustainable Equity
- Global Technology and Innovation
- U.S. Real Estate Securities
Emerging Markets
Europe
Asia Pacific
Insights
JH Explorer: AI update from Taiwan’s Computex
A trip to this year’s Computex trade show in Taipei reinforced our team’s bullish view on AI.
Small caps: Addressing the “stay-private” trend
Companies may be staying private longer, but that doesn’t diminish opportunities to capture early-stage growth in the small-cap universe.
JH Explorer: A firsthand look at the future of treating atrial fibrillation
Scrubbing in to watch multiple pulse field ablation procedures, we learned about the benefits and risks of this exciting new treatment option for AFib patients.
Institutional Insights
Sign up to get relevant content delivered straight to your inbox.